Balfaxar 1 UNT Injection

RxCUI
2643209
RxNorm name
Balfaxar 1 UNT Injection
Display name
Balfaxar 1 UNT Injection
Full name
Balfaxar 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125776BalfaxarProthrombin complex concentrate, human-lans351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BalfaxarPROTHROMBIN COMPLEX CONCENTRATE (HUMAN)Octapharma USA Inc68fa4f90-8b01-6498-4140-e0be5247c3fe2023-07-21Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2643209

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
68fa4f90-8b01-6498-4140-e0be5247c3feBalfaxar 1 UNT Injection [PSN] · coagulation factor IX, human-lans 1 UNT / coagulation factor X, human-lans 1 UNT / factor VII, human-lans 1 UNT / protein C, human-lans 1 UNT / protein S, human-lans 1 UNT / prothrombin, human-lans 1 UNT Injection [Balfaxar] [SBD] · Balfaxar 1 UNT Injection [SY]34These highlights do not include all the information needed to use BALFAXAR safely and effectively. See full prescribing information for BALFAXAR. BALFAXAR (prothrombin complex concentrate, human-lans) lyophilized powder for solution, for intravenous use Initial U.S. Approval: 202320230721